Xiao Liang

ORCID: 0000-0002-9711-5327 · 4 papers in corpus
other 2026
JMIR research protocols ·doi:10.2196/77423

BACKGROUND: Traditional Chinese medicine (TCM) functions according to the concepts of "holism" and treatment based on syndrome differentiation, and it has achieved good clinical results in treating patients with dysmenorrhea, which is a com…

review 2023
Frontiers in genetics ·doi:10.3389/fgene.2023.952379

Ovarian clear cell carcinoma (OCCC) is a rare subtype of epithelial ovarian cancer with unique molecular characteristics, specific biological and clinical behavior, poor prognosis and high resistance to chemotherapy. Pushed by the developme…

lab-animal 2022
·doi:10.2139/ssrn.4191376

Background: Coronavirus disease 2019 (COVID-19) treatments are still urgently needed for critically and severely ill patients. Human umbilical cord-mesenchymal stem cells (hUC-MSCs) infusion has therapeutic benefits in COVID-19 patients; ho…

observational 2020
Cancer management and research ·doi:10.2147/cmar.s286292

PURPOSE: Incidental gallbladder cancer (IGBC) is defined as gallbladder cancer (GBC) that is accidentally discovered during cholecystectomy to treat benign lesions. We aimed to compare the prognosis of IGBC patients who underwent simultaneo…